Although database analyses showed no significant difference in phosphoglycerate mutase 1 (PGAM1) expression level in ovarian cancer and normal tissues, the patients with high PGAM1 level were predicted to have poor PFS, PPS, and OS, which may be due to the inclusion of different ethnic and age groups in different databases. This evidence concerns the gene PGAM1 and ovarian cancer.